Live Breaking News & Updates on Ovo nordisk

Stay informed with the latest breaking news from Ovo nordisk on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Ovo nordisk and stay connected to the pulse of your community

Ozempic hits booze sales, Moderna likes AI, Biogen's blockbuster drug

Plus, Bernie Sanders launches an investigation into Wegovy and Ozempic prices, and Bristol-Myers Squibb prepares to lose lucrative patents

Bristol-myers-squibb , Novartis , Astrazeneca , Wall-street , Biogen , Iogen , Oderna , Penai , Ovartis , Erck , Egovy

Bernie Sanders Is Taking on Ozempic's 'Astronomically High' Price Tag

Senator Bernie Sanders (I-VT) is taking aim at one of Big Pharma’s newest cash cows: the latest generation of effective obesity medications. On Wednesday, Sanders’ office announced that the senator is launching an investigation into Novo Nordisk over the “astronomically high” list prices of their drugs Wegovy and Ozempic. Both drugs can cost around $1,000 a month or more without insurance coverage.

Germany , United-states , Americans , Eli-lilly , Instagram , Senate-health , Facebook , Twitter , United-states-congress , Novo-nordisk , Senator-bernie-sanders , Big-pharma

Sanders launches investigation into 'unacceptable' diabetes, weight loss drug prices

Sen. Bernie Sanders (I-Vt.), chair of the Senate Health, Education, Labor, and Pensions (HELP) Committee, on Wednesday launched an investigation into the “outrageously high prices” of Novo Nordisk’s respective diabetes and weight loss drugs, Ozempic and Wegovy. On Wednesday, Sanders penned a letter to Novo Nordisk’s chief executive officer, Lars Fruergaard Jørgensen, notifying him of…

United-states , Germany , United-kingdom , Canada , Americans , Lars-fruergaard , Wegovy-sanders , Yale-university , United-states-congress , Senate-health , Novo-nordisk , Bernie-sanders

Scholz promises support for pharma sector in Germany as Merck invests

German Chancellor Olaf Scholz said he was committed to supporting the pharmaceuticals sector with tax advantages for research and cutting red tape for trials at a ceremony with Merck, which is investing 1.5 billion euros ($1.61 billion) in Germany. The drugmaker plans to use its new life sciences Advanced Research Centre in the western city of Darmstadt, which it is spending 300 million euros on, to develop services and digital platforms to help scientists work more effectively. Scholz said he wanted Germany to build on a 2.3 billion euro investment by Eli Lilly in the western town of Alzey and other development plans by Novo Nordisk, BioNTech, AbbVie and Roche for Europe's biggest economy.

Germany , Berlin , German , Eli-lilly , Olaf-scholz , Andreas-rinke , Novo-nordisk , Pfizer , Research-centre , Chancellor-olaf-scholz , Advanced-research-centre , Madeline-chambers

Wegovy could treat millions of Medicare patients, study says

The popular weight loss drug could be covered for at least 3.6 million people under new Medicare rules, KFF says

United-states , Americans , Eli-lilly-zepbound , Eli-lilly , Medicaid-services , Drug-administration , Novo-nordisk , Kaiser-family-foundation , Centers-for-medicare , Medicare , Egovy , He-centers-for-medicare-and-medicaid-services

Ozempic and Wegovy prices spark U.S. Senate probe

Sen. Bernie Sanders sent a letter to Novo Nordisk's CEO asking the company reduce the price of its popular diabetes and weight loss drugs

United-states , Denmark , Germany , Canada , Danish , American , Americans , Lars-fruergaard , Novo-nordisk , Bernie-sanders , Vanderbilt-university , Senate-committee-on-health

Ozempic users spend less money at restaurants, survey finds

63% of survey respondents said they are spending less eating out at restaurants since they started taking the medication

Lars-fruergaard-jorgensen , Morgan-stanley , Novo-nordisk , Wendy , Bloomberg , Fruergaard-jorgensen , Business , Inance , Irzepatide , Ealth , Edical , Harma

3 Relatively Safe Growth Stocks You Can Buy and Hold

Low risk and high-reward potential? These stocks could offer both.

Denmark , Danish , David-jagielski-novo-nordisk , Bakiny-eli-lilly , Eli-lilly , Nvidia , Drug-administration , Keith-speights-vertex-pharmaceuticals , Vertex-pharmaceuticals , Alpine-immune-sciences , Novo-nordisk , Motley-fool

Eli Lilly under pressure: Can it solve GLP-1 supply squeeze?

Specific doses of Eli Lilly’s GLP-1 blockbuster drugs Mounjaro and Zepbound are currently facing a supply shortage, and frustrated patients are urging the pharma giant to act – fast.

Canada , India , Vietnam , Republic-of , David-ricks , Eli-lilly , Vikram-shanbhag , Nicolas-schmitz , Lilly-mounjaro , Lars-fruergaard , Novo-nordisk-wegovy , Novo-nordisk

Moderna's cancer vax, AstraZeneca CEO's big pay, record-high drug shortages

Plus, Harrow hikes the price of its eye medication 486%, and Pfizer wants the first FDA approval ever for an RSV vaccine for young adults

United-states , American , Pfizer , American-society-of-health , American-society , Health-system-pharmacists , Astrazeneca , Oderna , Ovartis , Denoviridae , Ealth